Association between Sickle Cell Trait and the Prevalence and Severity of Diabetic Retinopathy

Prevalence of Diabetic Retinopathy in a Population of Diabetics From the Middle East With Microvascular Ocular Motor Palsies

(2016) Alberto Gálvez-Ruiz et al.   JOURNAL OF NEURO-OPHTHALMOLOGY

Sickle Cell Trait Worsens Oxidative Stress, Abnormal Blood Rheology, and Vascular Dysfunction in Type 2 Diabetes

(2015) Mor Diaw et al.   DIABETES CARE

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

(2015) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Epidemiology of sickle cell disease in Saudi Arabia

(2011) Wasil Jastaniah   ANNALS OF SAUDI MEDICINE

Sickle Cell Trait and Development of Microvascular Complications in Diabetes Mellitus

(2010) A. J. Bleyer et al.   Clinical Journal of the American Society of Nephrology

Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration

(2010) L J Kopplin et al.   GENES AND IMMUNITY

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

The impact of malaria parasitism: from corpuscles to communities

(2009) Thomas E. Wellems et al.   JOURNAL OF CLINICAL INVESTIGATION

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

(2008) Nish Chaturvedi et al.   LANCET

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

(2008) Anne Katrin Sjølie et al.   LANCET